RPSA, ribosomal protein SA, 3921

N. diseases: 221; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0751007
Disease: Intracranial Atherosclerosis
Intracranial Atherosclerosis
0.050 Biomarker disease BEFREE <b>Background and Purpose:</b> Endovascular treatment (EVT) for acute vertebrobasilar intracranial atherosclerosis-related large vessel occlusion (ICAS-LVO) and its outcomes are not well known. 30941084 2019
CUI: C0751007
Disease: Intracranial Atherosclerosis
Intracranial Atherosclerosis
0.050 AlteredExpression disease BEFREE Identification of intracranial, atherosclerosis-related, large vessel occlusion (ICAS-LVO) is important to set up an optimal endovascular treatment strategy, as most ICAS-LVOs require specific endovascular modalities for efficient recanalization. 31040811 2019
CUI: C0751007
Disease: Intracranial Atherosclerosis
Intracranial Atherosclerosis
0.050 GeneticVariation disease BEFREE We also compared their outcomes with those of large vessel occlusion not associated with intracranial atherosclerosis (ICAS [-]-LVO). 30355204 2018
CUI: C0751007
Disease: Intracranial Atherosclerosis
Intracranial Atherosclerosis
0.050 Biomarker disease BEFREE Intracranial atherosclerosis of the anterior circulation (anterior ICAS) and intracranial atherosclerosis of the posterior circulation (posterior ICAS) are thought to involve different pathogeneses and risk factors. 28797616 2017
CUI: C0751007
Disease: Intracranial Atherosclerosis
Intracranial Atherosclerosis
0.050 GeneticVariation disease BEFREE Extracranial- and intracranial atherosclerosis (ECAS and ICAS) have been suggested to have different pathogeneses. 25042724 2014